Molecular characterization and antimicrobial susceptibility testing of Escherichia coli isolates from patients with urinary tract infections in 20 Chinese hospitals.
about
Epidemic potential of Escherichia coli ST131 and Klebsiella pneumoniae ST258: a systematic review and meta-analysisCTX-M Enzymes: Origin and Diffusion.Dominance of CTX-M-type extended-spectrum β-lactamase (ESBL)-producing Escherichia coli isolated from patients with community-onset and hospital-onset infection in China.Escherichia coli ST131, an intriguing clonal groupThe emergence of blaCTX-M-15-carrying Escherichia coli of ST131 and new sequence types in Western China.Antibiotic resistance pattern of different Escherichia coli phylogenetic groups isolated from human urinary tract infection and avian colibacillosis.Molecular characterization of multiresistant Escherichia coli producing or not extended-spectrum β-lactamases.Nationwide high prevalence of CTX-M and an increase of CTX-M-55 in Escherichia coli isolated from patients with community-onset infections in Chinese county hospitalsMolecular epidemiology and genetic diversity of fluoroquinolone-resistant Escherichia coli isolates from patients with community-onset infections in 30 Chinese county hospitalsPrevalence and distribution of beta-lactamase coding genes in third-generation cephalosporin-resistant Enterobacteriaceae from bloodstream infections in Cambodia.Similarity and divergence of phylogenies, antimicrobial susceptibilities, and virulence factor profiles of Escherichia coli isolates causing recurrent urinary tract infections that persist or result from reinfection.Antimicrobial resistance in Asia: current epidemiology and clinical implicationsAntimicrobial Resistance and Molecular Epidemiology of ESBL-Producing Escherichia coli Isolated from Outpatients in Town Hospitals of Shandong Province, ChinaPrevalence of ST1193 clone and IncI1/ST16 plasmid in E-coli isolates carrying blaCTX-M-55 gene from urinary tract infections patients in China.Epidemiology and genetics of CTX-M extended-spectrum β-lactamases in Gram-negative bacteria.Levofloxacin for the treatment of pyelonephritis.Cephalosporin resistant Escherichia coli from cancer patients in Cairo, Egypt.Genetic characterization of fluoroquinolone resistant Escherichia coli from urban streams and municipal and hospital effluents.Plasmidic qnr Genes Confer Clinical Resistance to Ciprofloxacin under Urinary Tract Physiological Conditions.High prevalence of fosfomycin resistance gene fosA3 in bla CTX-M-harbouring Escherichia coli from urine in a Chinese tertiary hospital during 2010-2014.Characterization of Ciprofloxacin-Resistant and Ciprofloxacin-Susceptible Uropathogenic Escherichia coli Obtained from Patients with Gynecological Cancer.Characterization of CTX-M-14-producing Escherichia coli from food-producing animals.CTX-M-27- and CTX-M-14-producing, ciprofloxacin-resistant Escherichia coli of the H30 subclonal group within ST131 drive a Japanese regional ESBL epidemic.In vitro activity of ceftolozane-tazobactam as determined by broth dilution and agar diffusion assays against recent U.S. Escherichia coli isolates from 2010 to 2011 carrying CTX-M-type extended-spectrum β-lactamases.Drug resistance and virulence of uropathogenic Escherichia coli from Shanghai, China.Molecular epidemiology and antimicrobial susceptibility of human Clostridium difficile isolates from a single institution in Northern China.
P2860
Q28073332-7D45898A-B0A4-40B4-A001-1F42FE0C3290Q30415141-9A8C9555-C9C4-406F-AB9E-A444336535AAQ33830187-A195502D-C992-4759-9AA0-3476A8A3B6CEQ34057648-54AAFCF8-5795-469C-ACB1-0BE843AAC6A0Q34465593-80A5CF68-31A6-41A9-A80E-597F6C54B2AEQ34475852-E516E057-6D8E-42B8-BE56-65AE0BC20897Q34668242-74FB76A2-F4FE-4F9A-B78B-DDA40CF91C51Q34694361-F54BC4A6-D5AC-491E-B5BC-3E03840F2748Q35331113-4D6BA63A-2ECC-429F-BD4C-A9157186CC5EQ35589184-26B057BA-6C11-4E36-8887-194D1AC94AB1Q36413968-385C64FC-FA6D-4B51-99CC-2A3AB9449315Q37192102-7696ED7B-0A21-4F10-9429-372B94480434Q37601374-47C083EE-105C-4A7B-9C84-FDBD7D45DCEFQ37719447-B54F561F-BF86-4973-9BD2-A2B3F93AE161Q38018625-E301E793-8E2A-4CC3-B853-DBC73079883EQ38101380-8517189B-F499-4BEC-B079-3BDB70DC5FACQ38855592-8547DEC4-A901-493F-9BC4-F19897A4D4B5Q40263075-C21F25FF-0C79-4A4E-B217-F7C4ADC42E78Q40368674-A1D1E409-2B32-4E8D-BE68-7C68D1C37AEFQ40415709-685BA028-4F08-4DCF-804F-83E0F0DFD85AQ40599029-0F10453C-B3A9-481E-95E2-DF69302FC49EQ40925539-EFBCC800-CE55-4E03-8D23-CDE65EEF8130Q41480033-12220B4A-B64B-41A9-B379-21C07FEB69D5Q43126004-45439D1C-4470-4766-BCA9-4573F42530F8Q54200152-46925FB2-96A9-4D7E-9214-4C28A2E71EABQ55430134-AFF356DF-E000-4D97-84E4-0A8BE5681405
P2860
Molecular characterization and antimicrobial susceptibility testing of Escherichia coli isolates from patients with urinary tract infections in 20 Chinese hospitals.
description
2011 nî lūn-bûn
@nan
2011 թուականի Ապրիլին հրատարակուած գիտական յօդուած
@hyw
2011 թվականի ապրիլին հրատարակված գիտական հոդված
@hy
2011年の論文
@ja
2011年論文
@yue
2011年論文
@zh-hant
2011年論文
@zh-hk
2011年論文
@zh-mo
2011年論文
@zh-tw
2011年论文
@wuu
name
Molecular characterization and ...... tions in 20 Chinese hospitals.
@ast
Molecular characterization and ...... tions in 20 Chinese hospitals.
@en
type
label
Molecular characterization and ...... tions in 20 Chinese hospitals.
@ast
Molecular characterization and ...... tions in 20 Chinese hospitals.
@en
prefLabel
Molecular characterization and ...... tions in 20 Chinese hospitals.
@ast
Molecular characterization and ...... tions in 20 Chinese hospitals.
@en
P2093
P2860
P50
P356
P1476
Molecular characterization and ...... tions in 20 Chinese hospitals.
@en
P2093
P2860
P304
P356
10.1128/JCM.02503-10
P407
P577
2011-04-27T00:00:00Z